TOPICAL SIROLIMUS 0.2% GEL FOR FACIAL ANGIOFIBROMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX IN THE UNITED STATES: A COST-EFFECTIVENESS ANALYSIS Dutta, S., Teng, J., Bhattacharyya, S., John, D., Boggarapu, S., Beresford, E. ELSEVIER SCIENCE INC. 2023: S155-S156

View details for Web of Science ID 001031473301061